DV
Dividend Vision

HLN — Haleon plc

Haleon plc (HLN)

HLN pays a 0.90% distribution rate, semi-annual. Its Distribution Safety Score™ is 50 (Caution). Total return is 37.5% over the past 4.1 years, 76.9 points behind SPY at 114.4%. Its deepest 1-year drawdown was 21.8%.

Haleon plc is a consumer healthcare company that researches, develops, manufactures, and sells over-the-counter products across oral health, vitamins and supplements, respiratory care, pain relief, and digestive health, with well-known brands including Sensodyne, Centrum, Theraflu, Voltaren, and Advil across North America, Europe, and Asia Pacific. The company offers a modest current distribution rate paid semi-annually. Haleon appeals to income-focused investors seeking exposure to established consumer healthcare brands with regular dividend payments.

HLN key facts

Distribution Safety Score™
50 · Caution
Asset type
Stock
Asset class
Equity
Inception date
07/18/2022
Distribution rate
0.90%
Distribution frequency
Semi-Annual
Trailing yield
2.01%
Last close
$9.70
Market cap
$42,717,474,816
Average volume
3292200.0
Last dividend
$0.0640
Ex-dividend date
08/14/2026
Payment date
09/17/2026
Beta
0.245
Payout ratio
0.0207
P/E ratio
19.7959
Forward P/E
18.018
EPS
$0.49